Last reviewed · How we verify

NCT06667401

Exploring the Efficacy of Assistive Artificial Intelligence for Ultrasound Guided Regional Anesthesia in Residency Training

Completed Last updated 3 March 2026
What this trial tests

trial testing The ScanNav, a novel artificial intelligence device designed to assist in Ultrasound guided regional anesthesia in Regional Anesthesia in 20 participants. Completed in 1 January 2026.

Timeline
10 March 2025
Primary endpoint
1 January 2026
1 January 2026

Quick facts

Lead sponsorMedical College of Wisconsin
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date10 March 2025
Primary completion1 January 2026
Estimated completion1 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical College of Wisconsin

Who can join

Eligibility, any sex, with Regional Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the efficacy of a novel artificial intelligence (AI) device designed to assist in Ultrasound guided regional anesthesia (ScanNav Anatomy Peripheral Nerve Block; ScanNav), in the teaching and training of anesthesiology residents in the subspecialty of regional anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Regional Anesthesia

Currently open trials in the same condition.

Other Medical College of Wisconsin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06667401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing